Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9NRD8: Variant p.Arg1492Cys

Dual oxidase 2
Gene: DUOX2
Feedback?
Variant information Variant position: help 1492 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help US The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Arginine (R) to Cysteine (C) at position 1492 (R1492C, p.Arg1492Cys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and polar (C) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help Found in a patient with very early onset inflammatory bowel disease; uncertain significance; no effect on subcellular location; significantly reduced ROS generation, which may decrease resistance to infection by enteric pathogens, such as Escherichia coli. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 1492 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1548 The length of the canonical sequence.
Location on the sequence: help FQKVLNRSLFTGLRSITHFG R PPFEPFFNSLQEVHPQVRKI The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         FQKVLNRSLFTGLRSITHFGRPPFEPFFNSLQEVHPQVRKI

Rat                           FQKVLNRSLFTGLRSVTHFGRPPFELFLDSLQEVHPQVHKI

Pig                           FQKVLNRSLFTGLRSITHFGRPPFEPFFNSLQEVHPQVRKI

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 26 – 1548 Dual oxidase 2
Topological domain 1266 – 1548 Cytoplasmic



Literature citations
Defects in NADPH oxidase genes NOX1 and DUOX2 in very early onset inflammatory bowel disease.
Hayes P.; Dhillon S.; O'Neill K.; Thoeni C.; Hui K.Y.; Elkadri A.; Guo C.H.; Kovacic L.; Aviello G.; Alvarez L.A.; Griffiths A.M.; Snapper S.B.; Brant S.R.; Doroshow J.H.; Silverberg M.S.; Peter I.; McGovern D.P.; Cho J.; Brumell J.H.; Uhlig H.H.; Bourke B.; Muise A.A.; Knaus U.G.;
Cell. Mol. Gastroenterol. Hepatol. 1:489-502(2015)
Cited for: POSSIBLE INVOLVEMENT IN INFLAMMATORY BOWEL DISEASE; VARIANTS CYS-1211 AND CYS-1492; SUBCELLULAR LOCATION;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.